chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 swollen lymph nodes appeared 10 days after vaccination; This is a spontaneous report from a contactable other healthcare professional (hcp). A 32-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EH9899, expiry date not reported), via an unspecified route of administration on 22Dec2020 14:30 at a single dose in the left arm for Covid-19 immunization. The patient had no medical history. Patient had no covid prior to vaccination. The patient had no known allergies: no allergies to medications, food, or other products. The patient was not pregnant at the time of the vaccination. The patient had no other vaccine in four weeks. The patient had birth control as other medication in two weeks prior to vaccination. Patient 2 swollen lymph nodes on 30Dec2020 20:30, which was also reported as appeared 10 days after vaccination in the hospital. They were located above left clavicle half way from middle of chest to arm, and easily palpable. No treatment received in response to the event and it resulted to emergency room/department or urgent care. The patient was not tested for COVID post vaccination. The outcome of the event 2 swollen lymph nodes was not recovered.
approximately 2 minutes after patient received vaccine he yelled out "I'm going to faint" and he laid down in supine position on floor and went unconscious. 2 staff members responded and positioned head to maintain his airway.  He was breathing and had pulse and was very pale. EMS was called. It took approximately 90 seconds for patient to become conscious again.  Cool cloth applied to head and verbal reassurance given to patient. Pt denied any injury. Pt stated he has fainted before with blood draws.  EMS arrived and evaluated pt and found his vital signs and heart rhythm  stable. Pt declined transport to hospital. Pts girlfriend came to drive him home.  He remained sitting in pharmacy waiting area for approximately 1 hour. He had food and water before leaving.
No other AE and no PQC; HBP calling to report an administration of an expired dose of MMR II was administered to a patient on 08/10/2023; This spontaneous report has been received from a "HBP" concerning a patient of unknown age and gender.  The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported.  On 10-AUG-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II), lot # U022175 (has been verified to be a valid lot number, expiration date reported and upon internal validation established as 14-JUL-2023) for prophylaxis (dose, anatomical location, and route of administration were not reported) (expired product administered). No symptoms or adverse events were reported.
At approx 11:15am provider scribe came to me and let me know a patient was ready for vaccine, I drew up vaccine went into the room and briefly asked patient if she was pt. in which she responded yes, had a small conversation and then I let her know provider ordered a TDap vaccine if she was okay to proceed with immunization and she agree it was okay. Vaccine was then administered without complications or c/o from patient. As I was walking out I let patient know she was okay to go to front window to check out and that is when patient let me know she was waiting on provider for medication refill, I told her pills are usually sent to pharmacy. She then told me she hasn't seen the provider yet which is the moment I realized she was not pt. I immediately let my provider and manager know.
Patient noticed rash on arm at injection site on Wednesday 7/27 after receiving vaccine on Monday 7/25. Rash was approximately 3" long by 1" wide (redness, no swelling).
rash was very red and in splotches; The rash worsened and itch; Rash around the waist, under her arms, down her legs; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (The rash worsened and itch), RASH (Rash around the waist, under her arms, down her legs) and RASH ERYTHEMATOUS (rash was very red and in splotches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 012A21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: ANTIBIOTICS (2 weeks prior vaccine). Concurrent medical conditions included Drug allergy (macrodantin) and Hypothyroidism. Concomitant products included TIMOLOL from 2012 to an unknown date and LATANOPROST from 2010 to an unknown date for Glaucoma, LEVOTHYROXINE SODIUM (LEVOTHYROXIN) from 1992 to an unknown date for Hypothyroidism, CLOTRIMAZOLE and MICONAZOLE NITRATE (ANTIFUNGAL [MICONAZOLE NITRATE]) for an unknown indication.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced RASH (Rash around the waist, under her arms, down her legs). On 06-Feb-2021, the patient experienced RASH PRURITIC (The rash worsened and itch). On an unknown date, the patient experienced RASH ERYTHEMATOUS (rash was very red and in splotches). The patient was treated with NYSTATIN at a dose of unknown; HYDROCORTISONE ACETATE (CORTIZONE [HYDROCORTISONE ACETATE]) in February 2021 for Itchy rash and Rash, at a dose of UNK dosage form; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) in February 2021 for Itchy rash and Rash, at a dose of UNK dosage form and TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE (GLUCOCORTICOID)) at a dose of unknown. At the time of the report, RASH PRURITIC (The rash worsened and itch) and RASH (Rash around the waist, under her arms, down her legs) was resolving and RASH ERYTHEMATOUS (rash was very red and in splotches) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitant medications included antifungal drugs.   This case was linked to MOD-2021-185621.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: significant follow up received on 27-MAY-2021 Contains dosage information was updated, concomitant medications was updated, events was updated, treatment information was provided.
chest tightness; unusual sensation on tongue; mild tingling; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (chest tightness), PARAESTHESIA ORAL (unusual sensation on tongue) and PARAESTHESIA (mild tingling) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included Glaucoma. Concurrent medical conditions included Kidney disorder, Drug allergy (Allergic to statins, Indocin, doxycycline and sulfa Repatha (possible PEG2000-DMG connection),) and Penicillin allergy. Concomitant products included HYDROCHLOROTHIAZIDE, METOPROLOL, LOSARTAN, LATANOPROST and TIMOLOL for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced CHEST DISCOMFORT (chest tightness), PARAESTHESIA ORAL (unusual sensation on tongue) and PARAESTHESIA (mild tingling). At the time of the report, CHEST DISCOMFORT (chest tightness), PARAESTHESIA ORAL (unusual sensation on tongue) and PARAESTHESIA (mild tingling) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Fallow up received and reporter information were added.
Information has been received from a registered nurse via a field representative referring to a patient of unknown age and gender. Information regarding concurrent conditions and medical history was not provided. On 22-JUL-2015 the patient was inadvertently vaccinated with a dose of (Oka/Merck) VARIVAX instead of a dose of ZOSTAVAX (dose, dose number, lot #, route and application site were not reported). Concomitant therapy was not reported. No adverse effects reported. Additional information has been requested.
HEADACHE, Myalgia, EXTREME FATIGUE Narrative: STAYED HOME FROM WORK
Patient was given Bivalent dose instead of second dose of primary series.  No treatment or side effects.
It was reported that a male pt received a Rabies Imovax ID and TD-TD ADS Adult vaccination on 08/10/1999. Reportedly several days after the injection the pt developed a blister like rash on arm, face and back. The pt reportedly was not seen by MD. From correspondence received on 10-4-1999, it was reported that the pt recovered from this experience. From correspondence received on 4/3/2000, additional vaccine and responsible physician information was provided.
Started with body aches then chills, got worse fever peaked at 103.3 24 hrs after the injection.  Still have body aches and  fever of 99.3 at 42 hrs.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Pertinent medical history, drug allergies or reactions were not reported. On 05-SEP-2014, the patient was vaccinated with a dose of (Oka/Merck) PROQUAD lot # K008185, expiry date: 05-DEC-2015 (dose and route were not reported) that underwent temperature excursion. Concomitant medication was not reported. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous case was reported by a patient and describes the occurrence of ALOPECIA (significant hair loss) and VACCINATION SITE PAIN (soreness in the site of injection) in a 70-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061F22A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: flu shot (Flu shot 1 month before bivalent booster.) in September 2022. Past adverse reactions to the above products included No adverse event with flu shot. Concurrent medical conditions included Drug allergy (Codeine) and Drug allergy (Vicodin).       No concomitant medication was reported.    Reportedly, patients doctor did not recommend any treatment and told her it would be solved within a few months. Patient wanted someone to call her back to follow up on her case and tell if this would stop.  Treatment details was not reported by the reporter.
Severe pain in deltoid, SCM, TMJ and occipitals 6 hours after injection. Headache. Lethargy.   About a week after, I could not walk and resulted in a total hip replacement.
Numbing and tingling sensation in my hands right after the shot. I have moderate carpal tunnel in both wrists so first thought I had was that it was affecting my nerves. Those symptoms resolved after two days. I was still able to perform tasks. A bit after that,  I also noticed my right eye lid drooping and my left eyelid was open and staring - like it was fixed. In next week and 1/2, I noticed symptoms consistent with my auto-immune  ( M. Gravis) disease my neck was getting stiff and range of motion in neck was constrained. I noticed stiffness in my shoulders. Those are areas where my disease has targeted before in the past. Those symptoms lasted a few days. I did  report these symptoms to my neurologist .  8th of May, I walk with a cane and I walked and afterward, I noticed pain in my left leg. The pain didn't stop and it got worse - it got so that every step I took hurt. I tried to deal with it for seven days. I thought at first that maybe I just had twisted something. On the 14th of May, I explained my symptoms to advice nurse. I received an appt on Monday and I went to see Dr. Bearing full weight on my left leg was excruciating and also on the left leg , I have had one old varicose vein for 15 years ( and no others on my body) but between the time of talking to the advice nurse and going to the doctor - 8 or 9 varicose veins popped up  within 48 hours- all were on the left leg except one. And they were all over from bottom of leg to hip. At the appt, she ordered an ultrasound. I've started to use the seated walker instead of cane and I'm walking shorter distances and trying to rest my leg and it is resolving. They have referred my to physical therapy to help with the compressed vertebrae. I don't use the analgesic they prescribed because it doesn't work- I mostly just rest it and use Tylenol when need.
pt had a positive COVID test 9/19/21; after hospitalizations for pulmonary problems related to COVID dx, pt presents to ED on 11/20/21 with dyspnea, hypoxia, confusion; lives in a SNF; worsening respiratory status; placed on NRB; A Fib with RVR; Long COVID dx; steroids, bronchodilators, mucolytics; progressive acute on chronic renal insufficiency with cardio renal syndrome; transitioned to comfort care and passed away in the hospital
overnight- fever, severe headache,  shaking chills, left arm pain (same arm as vaccine given.   Home care only, symptoms improved significantly over the next 24 hours PLEASE NOTE- Vaccine was given at pharmacy, all info on vaccine pt relayed from pharmacy
rash on chest; This case was reported by a consumer  and described the occurrence of rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was selected adult as per vaccine indication. The patient received a dose of shingrix and experienced rash on chest. The patient enquired if it was a normal side effect. No other information was reported.
Patient was given an expired vaccine, vaccine expired at 1230pm, and was given at 146pm, patient was contacted and came in 3/5/21 to be revaccinated.
pt devel rash on face & ears-rash very itchy;mom applying aveeno lotion & giving DPH;rash remains but resolving;
Began to feel feverish at 9pm after the shot was administered.  By 4am i felt terrible and had a fever.  Left arm felt like it was repeatedly hit with a baseball bat.  When i got home the entire shoulder was noticeably swollen.  It 1226pm on 2/5/21 and i still have body aches, chills, and no energy.  Had to call in sick to work last night due to the fever and body aches.
I developed a red, slightly burning rash within 24 hours.  Ocassional itching.  Right arm.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant and historical drugs was not provided. On 11-NOV-2011, the patient was vaccinated with the 1st dose of VAQTA and on 04-MAY-2012, the patient was vaccinated with the 2nd dose of VAQTA (route, anatomical location, lot # and expiration date were for both doses not provided) for prophylaxis. It was stated that this was shorter than the recommended interval. No adverse effects were reported.
PATIENT STATED THAT HE WOKE UP THIS MORNING AND THAT HIS ARM WAS SWOLLEN HARD TO LIFT. IT WAS THE ARM THAT PNEUMOVAX 23 WAS ADMINISTERED INTRAMUSCULARLY. NO FEVER OR PAIN WAS REPORTED BY PATIENT.
Patient stated she experienced extreme sharp pains in her stomach that started at 4am after the shot and lasted for 12 hours. She was unable to eat or drink due to the extreme pain. After about 12 hours she could only tolerate small sips of water for the rest of the day. Patient also reports severe headache and mild fever of 100.2 degrees F.
Patient reporting pain, swelling in right arm pit. Patient also reports feeling really tired , no appetite and blood sugar dropping really low.
Hypotension and bradycardia - responded to p.o. fluid, but persisting unstable B.P. and H.R. response upon ambulation after an hour of monitoring - transferred to local E.D.
Within 24 hrs. I experienced a headache after receiving vaccine and headache intensified within 72 hrs. Were not manageable with OTC pain medications. They were so severe I could not work and I did not feel safe to drive. Also experienced extreme dizziness and approx. 11 days the headaches were not goin away, I emailed my doctor and didn't get a response so I called and spoke to someone and did a phone visit and they suggested I got to UC since they had not gone away and it was 11 days post vaccination. I went to UC to rule out blood clots the did a CT San, basic metabolic panel, CBC w/ differential, WBC differential, EKG.
Pt states site of injection became warm and red with slight swelling. Pt states pain was worse than normal pain from anthrax vaccine and that prompted him to look at the site. Pt states no noted rash/hives, fever or chills. Pt states he used a hot compress on the site to reduce swelling and pain and this did help. Pt states the redness has gone away and swelling has gone down since using warm compress on the site.
Pt received 0.5ml of FLUZONE vaccine instead of 0.25ml IM on 10/22/18.
BLOOD CLOTS IN LUNGS; SHOULDER AND LEFT BREAST LEFT SIDE FEELS PARALYZED/ ARMS AND LEGS FEEL PARALYZED; HANDS, ARMS GOT TINGLING SENSATION; SWOLLEN THROAT; INFECTIOUS STUFF  THAT WAS COMING OUT OF HER MOUTH AND NOSE; This spontaneous report received from a patient concerned a 67 year old female of mixed race half white and half Indian and unknown ethnic origin. The patient's height, and weight were not reported. The patient's concurrent conditions included: non alcoholic, and non smoker, and the patient did not have known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, expiry: UNKNOWN) frequency one total, dose was not reported on right arm, administered on 05-APR-2021 for prophylactic vaccination. Concomitant medications included amlodipine besilate (10mg), hydroxyzine hydrochloride (25mg), Tradjenta (5mg), losartan (100mg), and paracetamol (Tylenol).  After three days of vaccination the patient could not breath, went to the hospital (emergency room) on 08-APRIL-2021. A radio dye was injected and the patient was diagnosed with blood clots in her lungs. The patient was coughing blood and had a swollen throat. The patient was treated with Antibiotics and Nasal Spray for infectious stuff that was coming out of her mouth and nose. She was released from the hospital on 08-Apr-2021. She was on Oxygen and cannot breath. The patient experienced shoulder and left breast -left side feels paralyzed / arms and legs feel paralyzed, hands, arms got tingling sensation. Treatment medications (dates unspecified) included: Xarelto (20mg) (rivaroxaban) The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blood clots in lungs, coughing blood, can't breath, shoulder and left breast -left side feels paralyzed / arms and legs feel paralyzed, swollen throat, and hands, arms got tingling sensation, and the outcome of infectious stuff that was coming out of her mouth and nose was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition). This case, from the same reporter is linked to 20210832472.; Sender's Comments: V0: 20210832975- covid-19 vaccine ad26.cov2.s-blood clots in lungs. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Fatigue - 8pm October 1 until 3pm, October 2 Fever and Chills 12midnight October 2 until 4am October 2 Body Aches 8pm October 1 until 3pm October 2nd Left arm swollen (size of egg), hurt, red and hot 8pm October 1 until 4pm October 4 (still)
A 7-month-old comes in today because of hives. Apparently this morning he had his influenza vaccine, the first of his series of two. About 2 hours after it, mother noticed a rash. His ears got red and swollen and the rash was red on his abdomen and arms. Seems to be starting to fade somewhat now. He has been acting okay. Never had any trouble breathing. Never developed a cough. Alert, pleasant white male, no distress. TM's pinkish-gray. Oropharynx is clear. Heat and lungs are clear. Abdomen soft. Skin, he does have an erythematous rash, fine macules around his abdomen. But he has several wheels on his arms. His ears are slight red. Urticaria, probably secondary to flu vaccine. Benadryl Elixir 4 ml every 6 hours for the next 2-3 days and until this rash goes away.
Headache, Myalgia, Fever, Temp: 102.0, no appetite Narrative:
Rash started 9/30/2015 on face and hands/feet.  Rash spread to all extremities and trunk and blisters developed within three days.  She was hospitalized for two days with diagnosis of Stevens-Johnson Syndrome where her large blisters were drained.  All blisters were healed within 4 weeks of onset.  Continues with faint red marks to this day.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Severe, Additional Details: Immediately after pt received vaccine, he stated he needed to lay down. His head/eyes rolled back, clinched hands in a fist and crossed hands then passed out/fainted. He came to and even though he said he was fine, still needed to lay down. Entire episode lasted 10-15 seconds. 911 called and paramedics took over.
Redness, pain and swelling at site ice, acetaminophen. Rx for SEPTRA should he not improve.
Hospitalized 12/29/21 2nd covid vaccine 2/13/21, pfizer.  Lote and location unknown 3rd pfizer covid vaccine 9/29/21, FF8841, IM L arm
arm pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14May2021 14:00 (Batch/Lot number: unknown) at the age of 41 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypertensive" (unspecified if ongoing); "COVID-19" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 15May2021 08:00, outcome "not recovered", described as "arm pain". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received Lisinopril 10 mlg within 2 weeks of vaccination. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.